Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
OTRICATH logo — company profile

OTRICATH

Founded 2016 2 employees Grant Total: $35.00K Biotechnology, Health Care +1

General Information

Company Name OTRICATH
Founded Year 2016
Employees 2
Industries Biotechnology, Health Care, Logistics and Delivery
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with OTRICATH. To contact OTRICATH, visit otricath.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does OTRICATH compare?

A PDF of OTRICATH and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting OTRICATH soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About OTRICATH

Otricath™, a biotechnology startup founded in 2016, introduces a groundbreaking solution for therapy delivery in the healthcare industry. Their patented platform technology facilitates the precise administration of cancer-fighting agents to solid tumors, ensuring exceptional control, predictability, and safety while minimizing systemic toxicity. The last recorded investment for Otricath was a $35.00K grant received on 16 May 2017, with contributions from MedTech Innovator and Texas A&M Innovation. This innovative approach has attracted significant attention from investors and industry experts, positioning Otricath as a promising player in the biotechnology and healthcare sectors.

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Grant $35.00K 2
MedTech Innovator Texas A&M Innovation
MedTech Innovator, Texas A&M Innovation
16 May 2017

OTRICATH Alternatives & Competitors

View All Alternatives
OTRICATH vs
Molecular Insight Pharmaceuticals
Molecular Insight Pharmaceuticals United States

Advancing patient healthcare with innovative molecular imaging and targeted radiotherapeutics in onc...

2 employees
Biotechnology, Health Care
OTRICATH vs
Actinium Pharmaceuticals, Inc.
Actinium Pharmaceuticals, Inc. United States

Targeted Therapies for Patients with Unmet Needs

Grant
58 employees
Biotechnology, Health Care
OTRICATH vs
VacV Biotherapeutics
VacV Biotherapeutics United Kingdom

Developing oncolytic viruses as therapeutics for cancer

Seed
6 employees
Biotechnology, Health Care
View all alternatives

FAQ About OTRICATH

Otricath™ offers a new approach to therapy delivery. This platform technology administers cancer-fighting agents to solid tumors with exceptional control, predictability, and safety, ensuring maximum therapeutic benefit and minimal systemic toxicity.
OTRICATH was founded in 2016.
OTRICATH operates in Biotechnology, Health Care and Logistics and Delivery.
OTRICATH has approximately 2 employees.
OTRICATH has completed 1 funding round, raising a total of $35.00K. The latest funding stage is Grant.
Top alternatives and competitors to OTRICATH include Molecular Insight Pharmaceuticals, Actinium Pharmaceuticals, Inc., VacV Biotherapeutics, Pacylex Pharmaceuticals, Inc., Viewpoint Molecular Targeting, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
OTRICATH and Molecular Insight Pharmaceuticals are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for OTRICATH, https://bouncewatch.com/company/otricath, updated 28 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes